Nitrogen fertilizer is widely used in row crop production and is a key expense farmers face each year. But often that fertilizer is wasted, washing away after heavy rains or leaching due to irrigation or poor soil quality.
Indigo Agriculture, the microbial ag products startup-cum-agribusiness marketplace has acquired TellusLabs, a startup using satellite imagery to monitors the world's croplands.
This Thanksgiving, we at AgFunder are thankful for our portfolio companies. Over the last year, we have invested in transformational food system companies, operating across the supply chain, from farm to fork.
Trace Genomics has built the first scalable soil microbiome test to help farmers predict soil disease, soil health, and crop quality, using high-throughput DNA sequencing and machine learning.
On our mission to democratize venture capital and increase investment in the food and agriculture industry, our fund is open to accredited investors as well as institutional investors, and we already have commitments from both.
“Pivot Bio is addressing one of the largest sources of GHGs on the planet – the potent nitrous oxide and carbon dioxide emissions associated with the use of synthetic fertilizers,” said Carmichael Roberts of Breakthrough Energy Ventures.
These provisions include funding for a new USDA pilot project that will incentivize farmers, through payments, to adopt agricultural practices aimed at improving soil health and sequestering organic soil carbon.
There's still a long way to go before we have a complete understanding of soil health and how it interacts with plant growth, according to Bill Buckner, president and CEO of the Noble Foundation.
The ag bioinformatics startup for the wine industry will be hiring new staff at its San Francisco and Spain locations to build out its microbial database and global service.
Indigo has raised $100 million in Series C funding as it launches its first commercial product, a microbial seed coating promoting water efficiency in cotton.
Dairy-free milk maker Ripple Foods raised its Series B funding round from a who's who in venture capital, while a microbiome testing company Trace Genomics raised $4m.
